Long-term carvedilol therapy increases parasympathetic nervous system activity in chronic congestive heart failure

被引:58
|
作者
Goldsmith, RL [1 ]
Bigger, JT [1 ]
Bloomfield, DM [1 ]
Krum, H [1 ]
Steinman, RC [1 ]
SacknerBernstein, J [1 ]
Packer, M [1 ]
机构
[1] COLUMBIA UNIV COLL PHYS & SURG, DIV CARDIOL, NEW YORK, NY 10032 USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 1997年 / 80卷 / 08期
关键词
D O I
10.1016/S0002-9149(97)00616-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To determine the effect of beta blockade on parasympathetic nervous system activity, we assessed RR variability during 24-hour Holter monitoring in 10 patients with congestive heart failure before and after 3 to 4 months of treatment with the beta blocker carvedilol. High-frequency-power increased from 26 to 64 ms(2), root-mean-square of successive differences in RR interval increased from 14.3 to 23.7 ms(2), and percentage of absolute differences >50 ms between successive normal RR intervals increased from 0.8% to 4.7%, all p <0.01, indicating a substantial increase in parasympathetic modulation of RR intervals.
引用
收藏
页码:1101 / +
页数:1
相关论文
共 50 条
  • [1] LONG-TERM THERAPY WITH DIGOXIN REDUCES SYMPATHETIC AND ENHANCES PARASYMPATHETIC NERVOUS-SYSTEM ACTIVITY IN CHRONIC HEART-FAILURE
    KRUM, H
    BIGGER, JT
    GOLDSMITH, RL
    PACKER, M
    CIRCULATION, 1993, 88 (04) : 108 - 108
  • [2] Long-term oral carvedilol in chronic heart failure
    Di Lenarda, A
    Sabbadini, G
    Moretti, M
    Sinagra, G
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (06) : 1359 - 1372
  • [3] LONG-TERM CAPTOPRIL THERAPY FOR CHRONIC CONGESTIVE HEART-FAILURE
    MASSIE, BM
    KRAMER, BL
    TOPIC, N
    AMERICAN JOURNAL OF CARDIOLOGY, 1984, 53 (09): : 1316 - 1320
  • [4] CHRONIC BETA-BLOCKER THERAPY WITH CARVEDILOL INCREASES PARASYMPATHETIC DRIVE IN HEART-FAILURE
    SCHRAMM, MS
    MARKS, ML
    OLSEN, SL
    GILBERT, EM
    CIRCULATION, 1993, 88 (04) : 104 - 104
  • [5] LONG-TERM THERAPY OF CHRONIC CONGESTIVE HEART-FAILURE WITH IBOPAMINE - A MULTICENTER TRIAL
    ROLANDI, E
    SABINO, F
    CANTONI, V
    GHIRARDI, P
    MARCHETTI, GV
    CICCHETTI, V
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 14 : S93 - S103
  • [6] EVALUATION OF LONG-TERM ORAL LEVODOPA THERAPY IN CHRONIC CONGESTIVE-HEART-FAILURE
    HASENFUSS, G
    KASPER, W
    MEINERTZ, T
    BUSCH, W
    LEHMANN, M
    KRAUSE, T
    HOFMANN, T
    REVENAUGH, M
    HOLUBARSCH, C
    JUST, H
    KLINISCHE WOCHENSCHRIFT, 1987, 65 (22): : 1087 - 1094
  • [7] BENEFICIAL LONG-TERM (1 YEAR) THERAPY OF CHRONIC CONGESTIVE HEART-FAILURE WITH PRAZOSIN
    BLEIFELD, W
    KUCK, KH
    HANRATH, P
    ACTA CARDIOLOGICA, 1982, : 49 - 52
  • [8] LONG-TERM ORAL ENOXIMONE THERAPY AND ARRHYTHMIA PROFILE IN CHRONIC CONGESTIVE HEART-FAILURE
    TREESE, N
    RHEIN, S
    WERNEYER, A
    ERBEL, R
    VONOLSHAUSEN, K
    POP, T
    MEYER, J
    ZEITSCHRIFT FUR KARDIOLOGIE, 1988, 77 (10): : 653 - 659
  • [9] PRENALTEROL AS LONG-TERM THERAPY FOR CHRONIC CONGESTIVE HEART-FAILURE - A RANDOMIZED CROSSOVER TRIAL
    DAHLSTROM, U
    ARESKOG, M
    WRANNE, B
    KARLSSON, E
    ACTA MEDICA SCANDINAVICA, 1984, 216 (02): : 199 - 207
  • [10] Down-regulation of sodium current in chronic heart failure: effect of long-term therapy with carvedilol
    V. A. Maltsev
    H. N. Sabbah
    A. I. Undrovinas
    Cellular and Molecular Life Sciences CMLS, 2002, 59 : 1561 - 1568